𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Migraine and Its Treatment with 5-HT1B/1D Agonists (Triptans)

✍ Scribed by Lorna Schumann; Maureen Moriarty-Sheehan

Book ID
111358949
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
274 KB
Volume
14
Category
Article
ISSN
1041-2972

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ChemInform Abstract: 5-Thienyltryptamine
ChemInform Abstract: 5-Thienyltryptamine Derivatives as Serotonin 5-HT1B/1D Receptor Agonists: Potential Treatments for Migraine.
✍ Charles Q. Meng; Suman Rakhit; David K. H. Lee; Rajender Kamboj; Kirk L. McCallu πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 37 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

5-HT1Freceptor agonists: A new treatment
5-HT1Freceptor agonists: A new treatment option for migraine attacks?
✍ Lars Neeb; Jannis Meents; Uwe Reuter πŸ“‚ Article πŸ“… 2010 πŸ› Springer-Verlag 🌐 English βš– 84 KB

Migraine is a debilitating disorder of the CNS. Although therapeutic options for migraine attacks have tremendously advanced with the development of triptans more than a decade ago, several conditions (such as vascular disease) restrict their use. Moreover, some patients do not respond to triptans a